Propiedad y actividad de insiders de Lineage Cell Therapeutics, Inc. (LCTX): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $1.07 |
| Capitalización | $267M |
| Bolsa | AMEX |
| País | US |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $22.1M | $36.8M | $23.6M | $9.5M | $32.6M | $55.7M | $11.4M | $35.4M | $45.8M | $40.8M |
| Inversiones a Corto | $627000 | $1.3M | $7.2M | $21.2M | $9.0M | $2.6M | $46.5M | $50000 | $2.0M | $15.0M |
| Cuentas por Cobrar | $1.2M | $3.0M | $3.7M | $24.7M | $4000 | $51.1M | $297000 | $745000 | $638000 | $1.6M |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $25.6M | $42.6M | $36.4M | $57.5M | $44.0M | $111.5M | $60.0M | $38.4M | $51.0M | $59.2M |
| Inmovilizado Material | $5.5M | $5.5M | $5.8M | $8.2M | $5.6M | $4.9M | $5.7M | $4.8M | $4.4M | $4.7M |
| Fondo de Comercio | 0 | 0 | 0 | $10.7M | $10.7M | $10.7M | $10.7M | $10.7M | $10.7M | $10.7M |
| Activos Intangibles | $10.2M | $6.9M | $3.1M | $48.2M | $47.0M | $46.8M | $46.7M | $46.6M | $46.5M | $31.7M |
| Activos Totales | $142.6M | $173.2M | $101.7M | $125.5M | $107.9M | $174.5M | $123.7M | $101.0M | $113.2M | $112.6M |
| Cuentas por Pagar | $1.6M | $938000 | $2.4M | $2.4M | $2.6M | $3.5M | $2.4M | $2.0M | $1.2M | $2.3M |
| Deuda a Corto | $932000 | $152000 | $70000 | $1.2M | $523000 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $8.8M | $6.9M | $6.8M | $6.5M | $7.8M | $47.1M | $19.0M | $18.0M | $14.0M | $11.4M |
| Deuda a Largo | $1.2M | $18000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $12.1M | $9.0M | $9.4M | $14.2M | $12.8M | $83.6M | $51.7M | $39.0M | $36.2M | $69.2M |
| Reservas | -$196.3M | -$216.3M | -$261.9M | -$273.4M | -$294.1M | -$337.1M | -$363.4M | -$384.9M | -$403.5M | -$467.0M |
| Patrimonio Neto | $117.9M | $162.6M | $93.8M | $113.0M | $96.2M | $92.2M | $73.3M | $63.4M | $78.4M | $44.5M |
| Deuda Total | $4.0M | $1.5M | $2.3M | $5.2M | $3.8M | $2.8M | $3.9M | $3.0M | $2.5M | $2.4M |
| Deuda Neta | -$18.7M | -$36.6M | -$28.5M | -$25.5M | -$37.7M | -$55.6M | -$54.0M | -$32.5M | -$45.3M | -$53.4M |
| Capital Circulante | $16.8M | $35.7M | $29.5M | $51.0M | $36.2M | $64.4M | $41.0M | $20.5M | $37.0M | $47.8M |
Salud financiera
| Deuda / Patrimonio | 0.04 |
| Ratio corriente | 6.61 |
Rentabilidad
| Rentabilidad sobre capital | -71.14% |
| Rentabilidad sobre capital invertido | -23.25% |
| Rentabilidad sobre activos | -30.37% |
| Margen bruto | 96.59% |
| Margen operativo | -205.23% |
| Margen neto | -246.58% |
Empresas relacionadas: ADCT · AUTL · BNTC · FULC · GALT · NGNE · OCGN
Explorar sector: Healthcare · Biotechnology
Más secciones de LCTX: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones